Cambridge, United Kingdom

Niall Martin

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Niall Martin: Innovator in Cancer Treatment

Introduction

Niall Martin is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of two patents, Martin's work focuses on DNA damage repair inhibitors that target specific pathways in cancer cells.

Latest Patents

Niall Martin's latest patents revolve around DNA damage repair inhibitors for the treatment of cancer. His inventions recognize that the inhibition of the base excision repair pathway is selectively lethal in cells deficient in homologous recombination (HR) dependent DNA double-strand break (DSB) repair. The methods and means he has developed relate to treating cancers that lack HR dependent DNA DSB repair by using inhibitors that target base excision repair components, such as PARP.

Career Highlights

Throughout his career, Niall Martin has worked with notable organizations, including Kudos Pharmaceuticals Limited and The Institute of Cancer Research. His research has been instrumental in advancing the understanding of cancer treatment and the mechanisms involved in DNA repair.

Collaborations

Some of Niall Martin's coworkers include Alan Ashworth and Stephen Philip Jackson. Their collaborative efforts have contributed to the development of innovative solutions in cancer research.

Conclusion

Niall Martin's work in developing DNA damage repair inhibitors represents a significant advancement in cancer treatment. His innovative approach and dedication to research continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…